Evidence map›Paper›PMID 31111045›Full record

Trial reportBioMed research international2019

Preoperative Management of MGD Alleviates the Aggravation of MGD and Dry Eye Induced by Cataract Surgery: A Prospective, Randomized Clinical Trial.

Peng Song, Zhuo Sun, Shengwei Ren, Kaili Yang, Guohua Deng, Qingyan Zeng, Yajie Sun

Open access · hybridAbstract readRandomized Controlled Trial
In one paragraph

Trial report in BioMed research international, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 1 pooled it
3.6field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 1 synthesis or guideline pooled it, 37 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Review
  5. Review
  6. Review
  7. Review
  8. Unhappy 20/20: A New Challenge for Cataract Surgery.Journal of clinical medicine · 2025
    Article
  9. Article
  10. Review
  11. Comparison of two treatments for dry eye disease after corneal refractive surgery.Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas · 2025
    Article
  12. Article
  13. Meibomian Gland Dysfunction Clinical Practice Guidelines.Japanese journal of ophthalmology · 2023
    Article
  14. Cataract surgery in ocular surface disease.Indian journal of ophthalmology · 2023
    Review
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Peng SongAier School of Ophthalmology, Central South University, Changsha, China.ORCID 0000-0002-4626-316X
Zhuo SunThe Third People's Hospital of Changzhou, Changzhou, China.ORCID 0000-0002-8987-1288
Shengwei RenProvincial People's Hospital, Henan Eye Hospital, Henan Eye Institute, People's Hospital of Zhengzhou University, Zhengzhou, China.
Kaili YangProvincial People's Hospital, Henan Eye Hospital, Henan Eye Institute, People's Hospital of Zhengzhou University, Zhengzhou, China.
Guohua DengThe Third People's Hospital of Changzhou, Changzhou, China.ORCID 0000-0003-2521-0744
Qingyan ZengAier School of Ophthalmology, Central South University, Changsha, China.ORCID 0000-0002-2478-9590
Yajie SunThe Third People's Hospital of Changzhou, Changzhou, China.ORCID 0000-0001-5461-6263
Changzhou Third People's Hospital · CNCentral South University · CNZhengzhou University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo investigate the effect of preoperative treatment and postoperative enhanced anti-inflammatory treatment on alleviating meibomian gland dysfunction (MGD) and dry eye induced by cataract surgery.

designProspective, randomized clinical trial.

methodsA total of 120 cataract patients with moderate obstructive-MGD were enrolled and randomized with 60:30:30 number of patients in cohorts I, II, and III, respectively: Cohort I: routine postoperative anti-inflammatory treatment; Cohort II: preoperative treatment (warming compress, lid hygiene, and anti-inflammatory treatment) and routine postoperative anti-inflammatory treatment; Cohort III: enhanced postoperative anti-inflammatory treatment. MAIN OUTCOMES MEASURES: All participants were examined preoperatively and postoperatively for ocular symptom score (OSS), noninvasive keratographic tear break-up time (NIKBUT), corneal fluorescein staining, Schirmer I test, lid margin, meibum quality and expressibility, and meibomian gland dropout.

resultsOcular surface disorders and MGD showed aggravated status at 1 month postoperatively in Cohort I and Cohort III, and the aggravated MGD resolved by 3 months postoperatively. At 1 month postoperatively, Cohort II and Cohort III presented high NIKBUT and low OSS, lid margin, and meibum quality and expressibility (Cohort II vs Cohort I: all

conclusionPreoperative management of MGD is effective and optimal in alleviating obstructive-MGD and dry eye induced by cataract surgery.

Indexed as

CataractAgedAnti-Inflammatory AgentsBlepharitisCataract ExtractionDry Eye SyndromesFemaleHumansMaleMeibomian GlandsMiddle AgedProspective StudiesTearsTreatment OutcomeAnti-Inflammatory Agents

Identifiers

PMID31111045
PMCPMC6487129
OpenAlexW2936151534

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.